Manulife (Manufacturers Life Insurance)’s The Oncology Institute TOI Stock Holding History
Bought
Maintained
Sold
Other funds holding TOI
VCM
DM
KWM
JAIC
WC
CP
Manulife (Manufacturers Life Insurance)'s TOI Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) increased its The Oncology Institute (TOI) stake by 0.29% in Q1 2026, buying an estimated $193 and bringing the position to 21,894 shares worth $67.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2696.
Manulife (Manufacturers Life Insurance) first reported a position in TOI in Q2 2025 and has held it in 4 quarters since. The position peaked at $77.7K in Q4 2025. 115 funds tracked by Wall St. Rank hold TOI as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 21,894 shares of The Oncology Institute worth $67.2K as of Q1 2026.
- Manulife (Manufacturers Life Insurance) bought 63 The Oncology Institute shares in Q1 2026, an estimated $193.
- The Oncology Institute made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2696 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in The Oncology Institute in Q2 2025 and has held it in 4 quarters since.
- Manulife (Manufacturers Life Insurance)'s The Oncology Institute position peaked at $77.7K in Q4 2025.
- 115 funds tracked by Wall St. Rank held The Oncology Institute as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.